Cell Isolation
& Enrichment
The Right Way.
True biology and real data for your research.
Cellular insights – Uncovered. Unaltered. Unbiased.
Any size, any type
No cell damage or activation
Discover your sample’s true biology by eliminating dyes, labels, and harsh processing
Simple and fast
Win the discovery race with a process that yields actionable results 80% faster than other methods
Experience the Levitation Difference.
Neuroscience
Decreased expression of activation markers in neural cells by 6x
Immunology
Oncology
From tissue to results with our end-to-end solutions
Easily obtain the truth that you are seeking with our integrated portfolio that enables you to:
- Minimize the cost and frustration of working with challenging samples
- Eliminate harsh techniques that can alter cells
- Significantly reduce processing times
LeviPrepTM Tissue Dissociation
Tunable cold dissociation in just 30 minutes
LeviCellTM Label-Free Enrichment
Enrich and purify precious cells of interest
LeviSelectTM Target Cell Enrichment
Isolate target cells, including subpopulations
LeviMetricsTM Sample Characterization
Gain deeper insights into your run results
A faster, easier and more reliable workflow than any other method.
80% faster. So simple anyone can run it.
LeviCell vs FACS & Beads – Up to 6x Less Steps and 5.8x Less Time
With unprecedented speed and fewer steps, why would you choose anything else?
We provide tools and solutions that allow you to see true biology for the first time. Our workflow does not induce the alterations, stress or damage common with other cell enrichment or sorting methods. We handle your cells with care – delivering the most viable and unaltered cells for actionable insights.
NextGen Omics US 2023
NextGen Omics US 2023
Bringing together leading omics experts from around the world and comprised of three outstanding programmes, delegates can expect to benefit from crit...
Interrogating Cancer Drivers via CRISPR – Webinar
Interrogating Cancer Drivers via CRISPR – Webinar
Interrogating Cancer Drivers via CRISPR: Mutant TP53 as a Therapeutic Target in Hypodiploid B-cell Acute Lymphoblastic Leukemia You are invited to a f...
Locations